Novanta is trading 4.04% up at $152.49, outperforming a weaker pre-market backdrop on September 14, 2026, ahead of its Baird Global Healthcare Conference presentation.
- Presentation is scheduled for September 15, with the CFO and COO participating.
- No fresh earnings release or other major company-specific announcement was identified overnight.
- Confidence is medium because the conference news was announced earlier.